Delivery Order SPE2DB24D2205-SPE2DB24FDSRL
Award Date
4/15/24
Potential Completion Date
4/16/24
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $7,377.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract, valued at $2,838.86, is a delivery order awarded under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a...
This federal contract award, valued at $1,576.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a completion date of February 21, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $8,905.59, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of February 19, 2025. The award was not designated with a set-aside requirement, indicating open competition....
This federal contract award reflects a delivery order placed with Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The delivery order, valued at $2,539.89, is for the provision of MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The award is part of a larger indefinite delivery contract (IDC) issued by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract, valued at $5,133.55, was awarded to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 2, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract has a ceiling value of $5,149.77 and is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract does not have a set-aside designation and is set to expire on June 17, 2024. Amerisourcebergen Drug Corp holds a larger...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, on January 8, 2024. The contract has a ceiling value of $3,041.01 and a completion date of January 9, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,192.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S medical supplies to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $8,687.77 and a period of performance through January 30, 2024. This is a delivery order contract with a firm fixed price pricing type. The...